Current Edition

Regional News

RLS bags $10M to trial dry powder inhaled CBD in anxiety

Investors have bought into Receptor Life Sciences’ vision of treating acute anxiety disorders using a dry powder inhaled cannabidiol (CBD). With $9.7 million in fresh...
Continue Reading →